Piavita

Piavita delivers a non-invasive system for continuous, real-time equine health monitoring. Its core offering is a wireless, palm-sized device that straps onto a horse, tracking vital signs via proprietary sensors. Integrated with a web application and base station, this system enables remote analysis, significantly enhancing proactive veterinary care.

Co-founded by Dorina Thiess and Sascha Buehrle, the company’s genesis came from Sascha’s insight in mountain bike suspension engineering inspiring the device. Dorina holds a PhD in business innovation from the University of St. Gallen, where she directed its Center for Entrepreneurship. Sascha contributes deep expertise in IoT, embedded systems, and healthcare IT.

Piavita serves veterinarians, horse clinics, and breeders, improving animal welfare and operational efficiency through continuous monitoring. This aids early detection and illness prevention, elevating equine care. The company plans to extend its technology to other animal species, broadening its digital health solutions.

High-Level Overview

Piavita AG is a Swiss veterinary medtech startup developing the Piavet System, a hardware-enabled SaaS platform for remote, continuous monitoring of equine vital signs. The system includes a measuring device, belt, and transfer station paired with a web platform, enabling vets to track horse health data like stress and conditions without physical presence, reducing travel and manual processes.[1][2][3] It serves equine veterinarians, clinics, universities, breeders, and sports riders in at least five countries, solving challenges in long-term, reliable vital data collection for sensitive horses.[1][2] Piavita has expanded internationally, with offices in Zürich, Berlin, and Charlotte, NC, capturing 20% of US university clinics as customers and launching Piavet 2.0 for enhanced features and user experience.[1]

Origin Story

Piavita originated from an idea sparked by founder Daniel Lehmann during downhill mountain bike racing, where he conceived a highly accurate sensor for measuring movements through materials, recognizing its potential for veterinary use in horses.[2] The Zurich-based company produces hardware in Switzerland and earned the prestigious CTI Start-up Label from the Swiss Commission for Technology and Innovation.[2][5] Key expansion came in early 2019 with a US office in Charlotte, NC, led by entrepreneur Dorina, leveraging stronger US digitization readiness; this has driven sales growth across Europe and North America.[1] Early traction included patents in sensor tech and increasing adoption in the veterinary field.[2]

Core Differentiators

• Stress-Free, Long-Term Monitoring: Breakthrough sensor technology enables reliable, continuous vital data collection on sensitive horses, unlike traditional methods requiring physical presence.[1][2]
• Full-Scale Hardware-SaaS Solution: Combines wearable hardware (device, belt, transfer station) with a multifunctional web platform for real-time insights, new features in Piavet 2.0, and superior user experience.[1][2][3]
• Manufacturing Flexibility: Partners with Protolabs for rapid 3D printing and overmolding of housings, allowing quick iterations without high fixed costs.[2]
• Market-Proven Traction: Sold in 5 countries, 20% US university clinic penetration, and recognition like CTI label; targets vets, breeders, and coaches.[1][2]

Role in the Broader Tech Landscape

Piavita rides the wave of digital transformation in veterinary medtech, particularly for equine healthcare, by replacing manual processes with AI-driven remote monitoring amid rising demand for connected systems.[1][5] Timing aligns with US clinics' tech adoption and global equine industry needs, where horses' sensitivity demands non-invasive tools; market forces like clinic efficiency pressures and data-driven care favor its growth.[1][2] It influences the ecosystem by digitizing vet workflows, enabling new services, and expanding to breeders/trainers, positioning as a holistic data leader in a niche underserved by general human medtech adaptations.[1][5]

Quick Take & Future Outlook

Piavita's momentum—fueled by Piavet 2.0, US traction, and production scalability—points to accelerated global expansion into more countries and user segments like sports equine markets.[1][2] Trends in animal health digitization, IoT wearables, and vet SaaS will propel it, potentially attracting acquisitions or further funding as equine medtech matures. Its sensor innovations could evolve influence from niche disruptor to industry standard, enhancing vet efficiency worldwide and tying back to its core mission of time-saving, intelligent equine care.[1][2][5]